6/10/2013 9:25:02 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CAMBRIDGE, Mass., June 10, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has appointed Charles Rowland to its Board of Directors. Mr. Rowland is Vice President and Chief Financial Officer of ViroPharma Incorporated. His appointment to Idenix's Board is effective immediately.
Help employers find you! Check out all the jobs and post your resume.
comments powered by